Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Orhub Inc (OP: ORHB )

0.0260 +0.0033 (+14.54%)
Streaming Delayed Price Updated: 2:05 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Orhub Inc

< Previous 1 2 3 Next >
HippoFi Finalizes an Exclusive Strategic Partnership with International Biomedical Manufacturing Company, BPB Medica
Via ACCESSWIRE
BioMedNewsBreaks – HippoFi Inc. (ORHB) Announces Launch of PURmarrow 360, Strategic Partnership for Near-Term Commercialization of New Technology
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
HippoFi is Finalizing Definitive Agreements to Join Forces with Industry Giant to Revolutionize the Spinal Biologic Market
Via ACCESSWIRE
HippoFi Anticipates a New Strategic Partnership as the Company Prepares to Launch PURmarrow 360, a Patented Stem Cell Harvesting Device
Via ACCESSWIRE
HippoFi's PUR Biologics Granted National Approval at the Veterans Health Administration (VHA), the Largest Integrated Healthcare System in the United States
Via ACCESSWIRE
PUR Biologics Begins Shipment of its Breakthrough Product PURbonedough(TM)
Via ACCESSWIRE
CORRECTION BY SOURCE: Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc.
Via ACCESSWIRE
PUR Biologics Expands Sales Network by 15%, Adding 32 New Distributors
Via ACCESSWIRE
Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc.
Via ACCESSWIRE
US Patent Office Grants PUR Biologics' Breakthrough Patent for Activating Immune Cells
Via ACCESSWIRE
PUR Biologics Launches PURfiberXP(TM), a Best-in-Class Cortical Fiber Matrix for Bone Regeneration
Via ACCESSWIRE
HippoFi Announces Its Return to a Pink Current Information Tier on the OTC Market
Via ACCESSWIRE
PUR Biologics Announces Launch of PURcore, a bioActive Moldable Synthetic for Spine Surgery
Via ACCESSWIRE
HippoFi Begins 2023 with Strong Sales of Advanced Biomaterials
Via ACCESSWIRE
HippoFi’s Regenerative Therapeutics Division, Launches PURbridge(TM) for Spine Surgery
Via ACCESSWIRE
HippoFi Signs Strategic Partnership Agreement with Precision Spine, Inc.
Via ACCESSWIRE
Company Update from Executive Chairman & CEO
Via ACCESSWIRE
ORHub Adopts New Name to Reflect Its Fintech Future - "HippoFi"
Via ACCESSWIRE
ORHub's PUR Biologics to Launch PUR Pillars
PUR PillarsTM were designed specifically for spine surgery, with a patient's post-surgical outcomes in mind. 
From ORHUB, Inc.
Via AccessWire
ORHub's PUR Biologics to Launch PUR Pillars
Via ACCESSWIRE
Orhub’s Ryan Fernan Becomes Head Of Pur Biologics, Leading Regenerative Therapeutic Efforts
A proven industry leader and executive, Ryan Fernan, will help ORHub advance Ortho-Spine technology beyond current limitations. 
From ORHUB, Inc.
Via AccessWire
Exposures Product Safety
Orhub’s Ryan Fernan Becomes Head Of Pur Biologics, Leading Regenerative Therapeutic Efforts
Via ACCESSWIRE
Healthcare Innovator "ORHub" Aims to Enter the Fintech Industry
Via ACCESSWIRE
Healthcare Innovator "ORHub" Aims to Enter the Fintech Industry
ORHub's new Surgical Resource Management ("SRM") platform, FutureOR, facilitates faster Case-to-Cash payments to medical device and biological vendors. 
From ORHUB, Inc.
Via AccessWire
Exposures Product Safety
ORHub Retains Predica to Launch New Software Platform
"ORHub to launch new FutureORTM application in Q3 2022" 
From ORHUB, Inc.
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
ORHub Acquires PUR Biologics, Entering the Global Medical Device Market
"PUR's technologies will bring new solutions for pain elimination and osteoarthritis." IRVINE, CA / ACCESSWIRE / April 25, 2022 / ORHub, Inc. (OTC PINK:ORHB) announced today it has purchased 100% of... 
From ORHUB, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
ORHub Prepares To Finalize Acquisition Of Pur Biologics
"ORHub plans to use PUR's patented technologies to treat osteoarthritis & joint cartilage" IRVINE, CA / ACCESSWIRE / April 15, 2022 / ORHub, Inc. (OTC Pink:ORHB) announced today it has reached a... 
From ORHUB, Inc.
Via AccessWire
ORHub, Inc. the Courts Rule To "Dismiss With Prejudice" the Lawsuit Brought by Frederic J. Buonincontri & Axt Analytics, LLC
IRVINE, CA / ACCESSWIRE / April 5, 2022 / ORHub, Inc. (OTC PINK:ORHB) ORHub announced today it has received the court ruling of an "ORDER DISMISSING WITH PREJUDICE" the litigation brought by Frederic... 
From ORHub, Inc.
Via AccessWire
Topics Lawsuit
Exposures Financial Legal
Orhub's Story Proves the Power of a Winning Culture
IRVINE, CA / ACCESSWIRE / March 14, 2022 / An Important message from the Chairman & CEO Dear Shareholders, It is an exciting time for ORHub. Our vision for the Company began in the operating room where... 
From ORHUB, Inc.
Via AccessWire
ORHub Executes Letter Of Intent For Acquisition
"ORHub continues to evaluate synergistic opportunities which add revenue and broaden market opportunity." IRVINE, CA / ACCESSWIRE / March 7, 2022 / ORHub, Inc. (OTC PINK:ORHB). ORHub today announced it... 
From ORHUB, Inc.
Via AccessWire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.